Data Manipulation Also Found In Tests of Novartis’ Valsartan At Jikei University
This article was originally published in PharmAsia News
After examination of data related to the Jikei Heart Study – valsartan research at Tokyo’s Jikei University School of Medicine carried out by Dr. Seibu Mochizuki – it was determined the blood pressure data was manipulated, the school announced.
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.